Cyclacel Pharmaceuticals Liabilities:
9.335M for Dec. 31, 2012Cyclacel Pharmaceuticals Historical Liabilities Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 9.335M |
| Sept. 30, 2012 | 7.297M |
| June 30, 2012 | 6.746M |
| March 31, 2012 | 6.802M |
| Dec. 31, 2011 | 6.498M |
| Sept. 30, 2011 | 5.935M |
| June 30, 2011 | 6.04M |
| March 31, 2011 | 6.813M |
| Dec. 31, 2010 | 6.535M |
| Sept. 30, 2010 | 7.965M |
| June 30, 2010 | 8.155M |
| March 31, 2010 | 9.511M |
| Dec. 31, 2009 | 8.594M |
| Sept. 30, 2009 | 9.595M |
| June 30, 2009 | 11.21M |
| March 31, 2009 | 9.966M |
| Dec. 31, 2008 | 10.32M |
| Sept. 30, 2008 | 11.85M |
| June 30, 2008 | 13.81M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
About Total Liabilities
Liabilities are obligations of a company arising from past transactions or events which are expected to reduce assets when they are settled.
Note : This is a simple term, but fairly complex topic. A company's balance sheet is made up of three components : Assets, Liabilities, and Shareholder's Equity. Assets are equivalent to the sum of liabilities and shareholder's equity.
Let's say a company sells computers. The assets would be the machinery, the plant, the inventory, etc. the company. However, the value of these assets belong to who funded the company. Is the company backed by obligations/debt (loans from a bank, inventory from a supplier)? or ... The founder / common public's (shareholder's equity)? Most likely, a combination of both.
Simply, liabilities are the part of a company's assets that it has yet to repay back.
Learn More
CYCC Liabilities Benchmarks
| Companies | |
|---|---|
| DARA Biosciences | 2.054M |
| 3SBio | 16.42M |
| Exelixis | 424.66M |
CYCC Liabilities Rankings
| Overall |
87th percentile 980 of 8002 |
| Sector |
72nd percentile 188 of 684 in Healthcare |
| Industry |
66th percentile 82 of 248 in Biotechnology |
CYCC Liabilities Range, Past 5 Years
| Minimum | 5.935M | Sep 2011 |
| Maximum | 13.81M | Jun 2008 |
| Average | 8.578M |
